Skip to main content
Clinical Trials/NCT02317952
NCT02317952
Completed
Not Applicable

A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein

Perrigo Nutritionals18 sites in 1 country90 target enrollmentMay 2014
ConditionsMilk Allergy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Milk Allergy
Sponsor
Perrigo Nutritionals
Enrollment
90
Locations
18
Primary Endpoint
Incidence of Allergic Reaction
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to determine if a new extensively hydrolyzed formula can be consumed by children with Cow's Milk Allergy.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
December 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Good health
  • Parent/guardian must be willing to provide informed consent
  • Parent/guardian agrees to feed study formula provided
  • Confirmation of Cow's Milk Allergy

Exclusion Criteria

  • No clinically significant abnormal findings on medical history, laboratory results, and physical exam.
  • No medications that may interfere with or impact evaluation of the study assessments
  • Allergy to extensively hydrolyzed casein formula
  • Tolerance of 200 ml of cow's milk, cow's milk-based formula or food products containing intact cow's milk protein within 2 weeks of the Screening Visit
  • Participation in another clinical trial within 30 days of screening where they are are receiving an active intervention

Outcomes

Primary Outcomes

Incidence of Allergic Reaction

Time Frame: 2 weeks

Secondary Outcomes

  • Growth(16 weeks)

Study Sites (18)

Loading locations...

Similar Trials